J&J and Bavarian Nordic start clinical tests of Ebola vaccine
January 06, 2015 at 02:21 AM EST
LONDON, Jan 6 (Reuters) - U.S. drugmaker Johnson & Johnson said on Tuesday it had started clinical trials of its experimental Ebola vaccine, which uses a booster developed by Denmark's Bavarian Nordic.
